Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 24Recruiting 7Unknown 6Active not recruiting 4Terminated 3Withdrawn 2Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Lung Neoplasms 3Thyroid Cancer, Papillary 2Prostatic Neoplasms 2Malignant Solid Neoplasm 2Hematopoietic and Lymphatic System Neoplasm 2Adenocarcinoma, Follicular 2Uterine Cervical Neoplasms 1Testicular Neoplasms 1Smoking Cessation 1Pancreatic Neoplasms 1Neoplasms 1Melanoma 1Malignant Female Reproductive System Neoplasm 1Genital Neoplasms, Female 1Endometrial Neoplasms 1Cigarette Smoking-Related Carcinoma 1Anatomic Stage I Breast Cancer AJCC v8 1ACT-GEN 1

Interventions

Exercise 9Standard of Care 5trametinib 3tislelizumab 3Radiotherapy 3Radiosurgery 3Palliative Care 3Paclitaxel 3Gemcitabine 3Carboplatin 3130-nm albumin-bound paclitaxel 3trastuzumab deruxtecan 2cemiplimab 2Therapeutics 2Surveys and Questionnaires 2Resistance Training 2Oxaliplatin 2Maintenance 2Immune Checkpoint Inhibitors 2Drug Therapy 2Cisplatin 2Anastrozole 2vedolizumab 1toripalimab 1surufatinib 1sparsentan 1sintilimab 1semaglutide 1posaconazole 1pomalidomide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Neoplasms × Interviews as Topic × Clear all
NCT07105046 2026-03-02

Facilitators and Barriers to Cancer Treatment Among Texas Residents

M.D. Anderson Cancer Center

Phase NA Not yet recruiting
120 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡